Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate and Severe COVID-19”

98 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 98 results

Not applicableAvailableNCT04657406
What this trial is testing

Expanded Access to Zofin for Patients With COVID-19

Who this might be right for
Covid19Corona Virus InfectionSARS (Severe Acute Respiratory Syndrome)+1 more
ZEO ScientifiX, Inc.
Post-approval studies (Phase 4)UnknownNCT04359316
What this trial is testing

Azithromycin in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Post-approval studies (Phase 4)UnknownNCT04350684
What this trial is testing

Umifenovir in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Testing effectiveness (Phase 2)Study completedNCT04392414
What this trial is testing

Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease

Who this might be right for
COVID-19
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia 60
Testing effectiveness (Phase 2)UnknownNCT04595136
What this trial is testing

Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient

Who this might be right for
SARS-CoV-2 Infection
United Medical Specialties 60
Large-scale testing (Phase 3)Ended earlyNCT04529499
What this trial is testing

Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients

Who this might be right for
Covid19
Dr. Reddy's Laboratories Limited 353
Not applicableUnknownNCT04953312
What this trial is testing

Calprotectin, a Biomarker of COVID-19 Severity (CALPRO)

Who this might be right for
Severe/Moderate CoronavirusChronic Myelomonocytic LeukemiaMyelodysplastic Syndromes+1 more
Assistance Publique - Hôpitaux de Paris 55
Not applicableStudy completedNCT07072793
What this trial is testing

A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe

Who this might be right for
COVID-19 (Coronavirus Disease 2019)
Pfizer 131,005
Testing effectiveness (Phase 2)UnknownNCT05787327
What this trial is testing

RCT for Yinqiaosan-Maxingganshitang in the Treatment of COVID-19

Who this might be right for
COVID-19
Chinese University of Hong Kong 96
Not applicableUnknownNCT05665205
What this trial is testing

Benefits of an Aerobic and Strength Rehabilitation Program With Post- SARS-CoV-2 Patients Moderate-severe

Who this might be right for
COVID-19
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 20
Not applicableStudy completedNCT04657445
What this trial is testing

EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY

Who this might be right for
Olfactory and Taste Dysfunction in SARS-CoV2 Infection
University Hospital, Ioannina 100
Early research (Phase 1)Study completedNCT04435522
What this trial is testing

Maraviroc in Patients With Moderate and Severe COVID-19

Who this might be right for
COVID
Rhode Island Hospital 9
Testing effectiveness (Phase 2)Study completedNCT04343768
What this trial is testing

An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 60
Testing effectiveness (Phase 2)Ended earlyNCT04582318
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19

Who this might be right for
SARS-CoV-2 Infection
NGM Biopharmaceuticals, Inc 16
Very early researchTemporarily pausedNCT04329572
What this trial is testing

Efficacy and Safety of Hydroxychloroquine and Azithromycin for Patients With Moderate to Severe COVID-19

Who this might be right for
COVID-19
Azidus Brasil 400
Testing effectiveness (Phase 2)UnknownNCT04622865
What this trial is testing

Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19

Who this might be right for
SARS-CoV 2COVID-19Coronavirus Disease 2019
AB Science 200
Testing effectiveness (Phase 2)UnknownNCT04338802
What this trial is testing

Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19

Who this might be right for
COVID-19NintedanibSafety+1 more
Huilan Zhang 96
Testing effectiveness (Phase 2)Study completedNCT04466098
What this trial is testing

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

Who this might be right for
Acute Respiratory Distress SyndromeARDS (Moderate or Severe)COVID-19 Pneumonia
Masonic Cancer Center, University of Minnesota 8
Large-scale testing (Phase 3)Study completedNCT05999435
What this trial is testing

Study of LAU-7b for the Treatment of Long COVID in Adults

Who this might be right for
Long COVID
Laurent Pharmaceuticals Inc. 272
Large-scale testing (Phase 3)UnknownNCT05445934
What this trial is testing

Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients With Moderate to Severe COVID-19 (BRIGHT Study)

Who this might be right for
COVID-19
Frontier Biotechnologies Inc. 1,188
Load More Results